| Nimotuzumab prolongs survival in patients with malignant gliomas: A phase I/II clinical study of concomitant radiochemotherapy with or without nimotuzumab | |
| Hong, Jidong; Peng, Yuping; Liao, Yuping; Jiang, Wuzhong; Wei, Rui; Huo, Lei; Han, Zaide; Duan, Chaojun; Zhong, Meizuo* | |
| 刊名 | Experimental and Therapeutic Medicine
 |
| 2012 | |
| 卷号 | 4期号:1页码:151-157 |
| 关键词 | malignant gliomas nimotuzumab temozolomide radiotherapy |
| ISSN号 | 1792-0981 |
| DOI | 10.3892/etm.2012.555 |
| URL标识 | 查看原文 |
| WOS记录号 | WOS:000305046100027 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3329345 |
| 专题 | 中南大学 |
| 作者单位 | 1.[Wei, Rui 2.Peng, Yuping 3.Liao, Yuping 4.Hong, Jidong 5.Zhong, Meizuo 6.Jiang, Wuzhong] Cent S Univ, Dept Oncol, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China. |
| 推荐引用方式 GB/T 7714 | Hong, Jidong,Peng, Yuping,Liao, Yuping,et al. Nimotuzumab prolongs survival in patients with malignant gliomas: A phase I/II clinical study of concomitant radiochemotherapy with or without nimotuzumab[J]. Experimental and Therapeutic Medicine,2012,4(1):151-157. |
| APA | Hong, Jidong.,Peng, Yuping.,Liao, Yuping.,Jiang, Wuzhong.,Wei, Rui.,...&Zhong, Meizuo*.(2012).Nimotuzumab prolongs survival in patients with malignant gliomas: A phase I/II clinical study of concomitant radiochemotherapy with or without nimotuzumab.Experimental and Therapeutic Medicine,4(1),151-157. |
| MLA | Hong, Jidong,et al."Nimotuzumab prolongs survival in patients with malignant gliomas: A phase I/II clinical study of concomitant radiochemotherapy with or without nimotuzumab".Experimental and Therapeutic Medicine 4.1(2012):151-157. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论